Video Transcript
In our pipeline. We have two products right now. One of them is treating high levels of phosphate in in the blood of patients. And this happens in patients in chronic kidney disease or on dialysis.
It’s the end stage renal disease. And the way this drug works is that once food is digested in the stomach, it releases phosphate. That phosphate is bound on our drug, which is a nanoparticle technology based drug, which is a very high surface area. It binds to this phosphate and forms an insoluble compound, which is then excreted from the body. And that’s exactly how it prevents the absorption of the phosphate from the gut, from the GI system into the bloodstream.